Patent · US Active

Nucleic acid molecules encoding alternansucrase

US7666632B2 · kind B2 · utility

0Cited by

1References

18Claims

0Family size

Assignee

Bayer Bioscience GmbH · DE

Inventors

Jens Kossmann · Golm, DE
Thomas Welsh · Lawrence, US
Martin Quanz · Berlin, DE
Karola Knuth · Berlin, DE

Key dates

Filing date	Oct 30, 2007
Grant date	Feb 23, 2010
Priority date	—
Expiry date	Feb 15, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2800/86
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Nucleic acid molecules encoding an alternansucrase are provided. Moreover, vectors, host cells and plant cells transformed by the herein-described nucleic acid molecules and plants containing them are provided. Furthermore, methods are described for preparing transgenic plants which synthesize the carbohydrate alternan, because of the insertion of nucleic acid molecules encoding an alternansucrase. Moreover, methods for preparing alternan and products resulting from them are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.